By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MorphoSys AG 

Lena-Christ-Strasse 48

Martinsried  Munich  82152  Germany
Phone: 49-0-89-899-27-0 Fax: 49-0-89-899-27-222



Company News
MorphoSys AG Announces Clinical Milestone For Start Of Bayer (BAY)'s Phase 2 Trial Designed To Support Registration Of Anetumab Ravtansine 1/26/2016 9:19:18 AM
MorphoSys AG To Present At J.P. Morgan Healthcare Conference 1/7/2016 10:21:55 AM
MorphoSys AG Deploys Dotmatics' Vortex to Accelerate Antibody Research 12/17/2015 11:23:01 AM
MorphoSys AG Presents Interim Safety, Pharmacokinetic And Efficacy Data For MOR202 In Multiple Myeloma At American Society of Hematology Meeting 12/7/2015 11:29:11 AM
New Clinical Data On MorphoSys AG’s Blood Cancer Drug Candidate MOR208 In NHL And CLL Presented At American Society of Hematology Annual Meeting 12/7/2015 11:22:17 AM
MorphoSys AG Announces Presentations at Upcoming American Society of Hematology Annual Meeting 2015 11/5/2015 12:37:17 PM
MorphoSys AG Reports Results For The First Nine Months Of 2015 11/4/2015 1:54:09 PM
MorphoSys AG Announces Clinical Milestone In Hemophilia Program With Bayer HealthCare (BAY) 10/30/2015 10:11:18 AM
MorphoSys AG To Host Q3 2015 Conference Call On November 4, 2015 10/28/2015 11:56:26 AM
MorphoSys AG And immatics biotechnologies GmbH Enter Strategic Alliance In Immuno-oncology 8/25/2015 8:28:04 AM